Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript

Emergent BioSolutions Inc. misses on earnings expectations. Reported EPS is $-0.77 EPS, expectations were $-0.33. Emergent BioSolutions Inc.

Keep Reading →